These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19756496)

  • 1. Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model.
    Cui X; Su J; Li Y; Shiloach J; Solomon S; Kaufman JB; Mani H; Fitz Y; Weng J; Altaweel L; Besch V; Eichacker PQ
    Intensive Care Med; 2010 Jan; 36(1):148-56. PubMed ID: 19756496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.
    Qiu P; Li Y; Shiloach J; Cui X; Sun J; Trinh L; Kubler-Kielb J; Vinogradov E; Mani H; Al-Hamad M; Fitz Y; Eichacker PQ
    J Infect Dis; 2013 Sep; 208(6):978-89. PubMed ID: 23737601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.
    Cui X; Li Y; Li X; Laird MW; Subramanian M; Moayeri M; Leppla SH; Fitz Y; Su J; Sherer K; Eichacker PQ
    J Infect Dis; 2007 Feb; 195(4):572-80. PubMed ID: 17230417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
    Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ
    J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
    Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
    Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats.
    Cui X; Moayeri M; Li Y; Li X; Haley M; Fitz Y; Correa-Araujo R; Banks SM; Leppla SH; Eichacker PQ
    Am J Physiol Regul Integr Comp Physiol; 2004 Apr; 286(4):R699-709. PubMed ID: 14715494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis lethal toxin alters regulation of visceral sympathetic nerve discharge.
    Garcia AA; Fels RJ; Mosher LJ; Kenney MJ
    J Appl Physiol (1985); 2012 Mar; 112(6):1033-40. PubMed ID: 22114180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovir.
    Suffredini DA; Li Y; Xu W; Moayeri M; Leppla S; Fitz Y; Cui X; Eichacker PQ
    Am J Physiol Heart Circ Physiol; 2017 Nov; 313(5):H946-H958. PubMed ID: 28887331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model.
    Sherer K; Li Y; Cui X; Li X; Subramanian M; Laird MW; Moayeri M; Leppla SH; Fitz Y; Su J; Eichacker PQ
    Crit Care Med; 2007 Jun; 35(6):1560-7. PubMed ID: 17452924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
    Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
    BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Immune Interactions between
    Liu JZ; Ali SR; Bier E; Nizet V
    Front Cell Infect Microbiol; 2018; 8():2. PubMed ID: 29404280
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacillus anthracis edema but not lethal toxin challenge in rats is associated with depressed myocardial function in hearts isolated and tested in a Langendorff system.
    Li Y; Abu-Asab M; Su J; Qiu P; Feng J; Ohanjanian L; Kumar HS; Fitz Y; Eichacker PQ; Cui X
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1592-602. PubMed ID: 25862834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
    Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
    Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival.
    Cui X; Li Y; Li X; Haley M; Moayeri M; Fitz Y; Leppla SH; Eichacker PQ
    J Infect Dis; 2006 Mar; 193(6):829-40. PubMed ID: 16479518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
    Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD
    Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
    Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.
    Altaweel L; Chen Z; Moayeri M; Cui X; Li Y; Su J; Fitz Y; Johnson S; Leppla SH; Purcell R; Eichacker PQ
    Crit Care Med; 2011 Jun; 39(6):1439-47. PubMed ID: 21336113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological effects of anthrax lethal factor on rat liver.
    Altunkaynak BZ; Ozbek E
    J Immunotoxicol; 2015; 12(1):33-9. PubMed ID: 24344743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.